IL33 and inflammatory bowel disease: Some studies show its protective function in restoring goblet cell numbers and switching macrophage phenotype from M1 (pro-inflammatory) to M2 (wound healing) [46]; other studies propose that IL-33 and its ligand ST2 are involved in IBD pathogenesis by increasing intestinal barrier permeability [47].